These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19558574)

  • 21. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S; Hendi K; Pakravan M
    J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical and surgical treatment of neovascular glaucoma.
    Olmos LC; Lee RK
    Int Ophthalmol Clin; 2011; 51(3):27-36. PubMed ID: 21633236
    [No Abstract]   [Full Text] [Related]  

  • 23. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
    Vatavuk Z; Bencic G; Mandic Z
    Eur J Ophthalmol; 2007; 17(2):269-71. PubMed ID: 17415704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravitreal bevacizumab for neovascular glaucoma.
    Vasudev D; Blair MP; Galasso J; Kapur R; Vajaranant T
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):453-8. PubMed ID: 19857107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal injection of bevacizumab to treat neovascular glaucoma.
    Kubota T; Aoki R; Harada Y; Tou N; Tawara A
    Jpn J Ophthalmol; 2008; 52(5):410-412. PubMed ID: 18991046
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
    Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
    J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.
    Falavarjani KG; Modarres M; Nazari H
    Eye (Lond); 2010 Apr; 24(4):717-9. PubMed ID: 19407842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma.
    Yokoyama K; Choshi T; Kimoto K; Shinoda K; Nakatsuka K
    Acta Ophthalmol; 2008 Dec; 86(8):927-8. PubMed ID: 18494739
    [No Abstract]   [Full Text] [Related]  

  • 33. Bevacizumab as adjuvant for neovascular glaucoma.
    Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
    Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J; Jorge R; Alves Costa R; Rodrigues Mde L; Scott IU
    Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
    Sothornwit N
    J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.
    Miki A; Oshima Y; Otori Y; Matsushita K; Nishida K
    Eye (Lond); 2011 May; 25(5):658-9. PubMed ID: 21423145
    [No Abstract]   [Full Text] [Related]  

  • 37. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO; Albert MA; Mays A; Vail R
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration].
    Geitzenauer W; Michels S; Prager F; Kornek G; Vormittag L; Rosenfeld P; Schmidt-Erfurth U
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):822-7. PubMed ID: 17063425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
    Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
    J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: systematic review].
    Martínez-Carpio PA; Bonafonte-Márquez E; Heredia-García CD; Bonafonte-Royo S
    Arch Soc Esp Oftalmol; 2008 Oct; 83(10):579-88. PubMed ID: 18855277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.